Clinical Trials Browser

Phase 2 × Nasopharyngeal Neoplasms × Injections × Clear all

NCT06892431 2025-03-25

JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer

Phase 2 Not yet recruiting

Nasopharyngeal Neoplasms, Recurrence